The largest and most expansive research focus at UVM is in the biomedical sciences, which accounts for well over two-thirds of the external funding that comes to the University. Ranging from the study of cancer at the molecular level, to bioengineering new lungs, to saving patients in their critical first hours after a stroke, physicians and biomedical scientists at UVM are engaged in creating new knowledge about disease and wellness at every level. Transformative milestones of discovery at UVM happen in the basic, clinical and behavioral sciences, and faculty are proving adept at successfully navigating an increasingly competitive landscape while continuing to serve in national leadership roles and mentoring the next generation of physicians and scientists.
Beth Kirkpatrick, M.D., Professor of Medicine & Director of the Vaccine Testing Center
The University of Vermont's Vaccine Testing Center (VTC) plays a key role in the fight against infectious diseases that impact much of the world's population.
Peter Spector, M.D., Professor of Medicine
As a cardiologist, Peter Spector, M.D., has seen his share of patients suffering from the nation's most common heart rhythm disorder, atrial fibrillation (AF).
Daniel Weiss, M.D., Ph.D., Professor of Medicine
In end-stage lung disease, transplantation is sometimes the only viable therapeutic option, but organ availability is limited and rejection presents an additional challenge.
Eyal Amiel, Ph.D., Assistant Professor of Medical Laboratory and Radiation Sciences
Microbiologist Eyal Amiel, Ph.D., didn't think he wanted to study immunology, let alone make a career of it. But as co-author of a paper recently published in the journal Nature Immunology, Amiel is at the forefront of research that could eventually lead to changes in vaccine design, along with new approaches to treating immune-related diseases.
Bryan Ballif, Ph.D., Associate Professor of Biology
In the early 1950's, a 66-year-old woman, sick with colon cancer, received a blood transfusion. Then, unexpectedly, she suffered a severe rejection of the transfused blood. Reporting on her case, the French medical journal Revue D'Hématologie identified her as, simply, "Patient Vel."
Vermont Cancer Center Researchers Target Epigenetic Mechanisms to Advance Cancer Detection and Treatment
Gary Stein, Ph.D., Claire Verschraegen, M.D., Marie Wood, M.D., Kaleem Zaidi, Ph.D.
Researchers at the Vermont Cancer Center (VCC) at the University of Vermont and Fletcher Allen Health Care are transforming the understanding of cancer biology and treatment of cancer.